Faeth Therapeutics
FTH
Faeth Therapeutics (FTH) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Needham | Initiated Coverage | Buy | $56.00 | Aug 21, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $60.00 | Aug 11, 2026 |
| Jones Trading | Initiated Coverage | Buy | $55.00 | Aug 4, 2026 |
| Raymond James | Initiated Coverage | Outperform | $56.00 | Jul 31, 2026 |
| Oppenheimer | Initiated Coverage | Outperform | $60.00 | Jul 28, 2026 |
| Citizens | Initiated Coverage | Market Outperform | $51.00 | Jul 20, 2026 |
| BTIG | Maintained | Buy | $55.00 | Jul 16, 2026 |
| Baird | Initiated Coverage | Outperform | $57.00 | Jun 26, 2026 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $60.00 | Jun 22, 2026 |
| BTIG | Maintained | Buy | $55.00 | Jun 15, 2026 |
| BTIG | Initiated Coverage | Buy | $55.00 | Jun 11, 2026 |
| Cantor Fitzgerald | Initiated Coverage | Overweight | — | May 29, 2026 |
| LUCID CAPITAL MARKETS | Initiated Coverage | Buy | $50.00 | May 28, 2026 |
| Citigroup | Initiated Coverage | Buy | $55.00 | May 22, 2026 |
| HC Wainwright & Co. | Downgraded | Buy → Neutral | — | Oct 30, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $30.00 from $5.00 | Aug 5, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $5.00 | Jun 2, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $4.00 | Mar 28, 2025 |
| Oppenheimer | Maintained | Outperform | $4.00 from $3.50 | Mar 28, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $4.00 | Jan 10, 2025 |
Frequently asked questions
What is the latest analyst rating on FTH?
On Aug 21, 2026, Needham initiated coverage of Faeth Therapeutics at Buy with a price target of $56.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.